HMPL-A580 Clinical Trials (2026): 1 Studies for Solid Tumors, Adult

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

1 HMPL-A580 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Solid Tumors, Adult) and 186 total planned enrollment. 1 HMPL-A580 clinical trial is actively recruiting. Most recent activity: NCT07396584 (Jan 2029).

HMPL-A580 clinical trials at a glance: phase × recruitment status

PhaserecruitingTotal
P1/P211

Recruiting HMPL-A580 clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT07396584HMPL-A580 in Participants With Advanced or Metastatic Solid TumorP1/P2Solid Tumors, Adult186Mar 2026

All HMPL-A580 trials (1)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT07396584HMPL-A580 in Participants With Advanced or Metastatic Solid TumorP1/P2recruiting186HutchmedMar 2026

HMPL-A580 clinical trials: frequently asked questions

How many HMPL-A580 clinical trials are there?
1 HMPL-A580 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
Are HMPL-A580 clinical trials recruiting in 2026?
Yes — 1 HMPL-A580 trial is actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
What conditions is HMPL-A580 being studied for?
HMPL-A580 is being studied for Solid Tumors, Adult. The trials are grouped by indication on this page.
Who sponsors HMPL-A580 clinical trials?
The lead sponsor across the most HMPL-A580 trials is Hutchmed. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming HMPL-A580as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai: